The University of Southampton
University of Southampton Institutional Repository

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement
Specific immunotherapy (SIT) is one of the treatments for allergic rhinitis. However, for allergists, nonspecialists, regulators, payers, and patients, there remain gaps in understanding the evaluation of randomized controlled trials (RCTs). Although treating the same diseases, RCTs in SIT and pharmacotherapy should be considered separately for several reasons, as developed in this study. These include the severity and persistence of allergic rhinitis in the patients enrolled in the study, the problem of the placebo, allergen exposure (in particular pollen and mite), the analysis and reporting of the study, the level of symptoms of placebo-treated patients, the clinical relevance of the efficacy of SIT, the need for a validated combined symptom-medication score, the differences between children and adults and pharmacoeconomic analyses. This statement reviews issues raised by the interpretation of RCTs in sublingual immunotherapy. It is not possible to directly extrapolate the rules or parameters used in medication RCTs to SIT. It also provides some suggestions for the research that will be needed. Interestingly, some of the research questions can be approached with the available data obtained from large RCTs
immunotherapy, randomized controlled trials, rhinitis, subcutaneous, sublingual, symptom score
0105-4538
765-774
Bousquet, J.
fda25127-be6f-45cd-a455-883cc90d8e0e
Schünemann, H.J.
eb3ceb01-391d-47eb-93af-3ccbc2729144
Bousquet, P.J.
dc9a9b8f-d26c-47ee-9d0e-204ed1dcd747
Bachert, C.
8c8c352e-288f-47bd-9fb5-1ead1b20fcbd
Canonica, G.W.
b9d303f8-7c7d-4e9f-8b51-a92374d98ea0
Casale, T.B.
b0477cb6-4900-41e4-afc2-73091ea4418e
Demoly, P.
2aa3f6d3-44a5-426b-b327-a63249b70c96
Durham, S.
fad2d5de-ec3c-4f7b-aebc-2e6218b727e9
Carlsen, K.-H.
eb79a0a9-897a-4435-bc83-76f414e77604
Malling, H.-J.
66174d27-3cdd-42be-9afc-36be9c1c1b36
Passalacqua, G.
e740c929-6567-46bc-b60c-78679f6a174a
Simons, F.E.R.
7af30030-8a44-4f61-93c2-23beecf1420c
Anto, J.
cbaf6521-b10f-42aa-b60d-55e559db8df6
Baena-Cagnani, C.E.
7f31c5f8-6b1c-4803-b8bd-b2300753411b
Bergmann, K.-C.
e18eb2e6-c9f6-41b5-ae64-2d79ec42c886
Bieber, T.
b55a872a-62c0-4e7c-bc84-11df03fb087f
Briggs, A.H.
e23075be-c921-4d21-9509-797810cf68f0
Brozek, J.
009e958f-fffe-4079-ae66-6b8a31b56502
Calderon, M.A.
338bcaf9-5912-496c-b0ba-07e8344064ec
Dahl, R.
ca31be56-52e7-433a-b60e-25e5aba41f78
Devillier, P.
543ddb5b-59fe-44d1-af5b-0991951e34b2
Gerth van Wijk, R.
64d21a3b-ed5a-46ae-a2d2-35478f0ea484
Howarth, P.
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Larenas, D.
c8e5b02d-c8c1-400a-ad3a-fbec9a46b3d7
Papadopoulos, N.G.
fac5aea9-7ee2-4579-90c8-e547b6a4bdf7
Schmid-Grendelmeier, P.
29341ce4-00e3-4dda-a975-af8abdd67783
Zuberbier, T.
bc707651-5e30-4172-8932-41c003022241
Bousquet, J.
fda25127-be6f-45cd-a455-883cc90d8e0e
Schünemann, H.J.
eb3ceb01-391d-47eb-93af-3ccbc2729144
Bousquet, P.J.
dc9a9b8f-d26c-47ee-9d0e-204ed1dcd747
Bachert, C.
8c8c352e-288f-47bd-9fb5-1ead1b20fcbd
Canonica, G.W.
b9d303f8-7c7d-4e9f-8b51-a92374d98ea0
Casale, T.B.
b0477cb6-4900-41e4-afc2-73091ea4418e
Demoly, P.
2aa3f6d3-44a5-426b-b327-a63249b70c96
Durham, S.
fad2d5de-ec3c-4f7b-aebc-2e6218b727e9
Carlsen, K.-H.
eb79a0a9-897a-4435-bc83-76f414e77604
Malling, H.-J.
66174d27-3cdd-42be-9afc-36be9c1c1b36
Passalacqua, G.
e740c929-6567-46bc-b60c-78679f6a174a
Simons, F.E.R.
7af30030-8a44-4f61-93c2-23beecf1420c
Anto, J.
cbaf6521-b10f-42aa-b60d-55e559db8df6
Baena-Cagnani, C.E.
7f31c5f8-6b1c-4803-b8bd-b2300753411b
Bergmann, K.-C.
e18eb2e6-c9f6-41b5-ae64-2d79ec42c886
Bieber, T.
b55a872a-62c0-4e7c-bc84-11df03fb087f
Briggs, A.H.
e23075be-c921-4d21-9509-797810cf68f0
Brozek, J.
009e958f-fffe-4079-ae66-6b8a31b56502
Calderon, M.A.
338bcaf9-5912-496c-b0ba-07e8344064ec
Dahl, R.
ca31be56-52e7-433a-b60e-25e5aba41f78
Devillier, P.
543ddb5b-59fe-44d1-af5b-0991951e34b2
Gerth van Wijk, R.
64d21a3b-ed5a-46ae-a2d2-35478f0ea484
Howarth, P.
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Larenas, D.
c8e5b02d-c8c1-400a-ad3a-fbec9a46b3d7
Papadopoulos, N.G.
fac5aea9-7ee2-4579-90c8-e547b6a4bdf7
Schmid-Grendelmeier, P.
29341ce4-00e3-4dda-a975-af8abdd67783
Zuberbier, T.
bc707651-5e30-4172-8932-41c003022241

Bousquet, J., Schünemann, H.J., Bousquet, P.J., Bachert, C., Canonica, G.W., Casale, T.B., Demoly, P., Durham, S., Carlsen, K.-H., Malling, H.-J., Passalacqua, G., Simons, F.E.R., Anto, J., Baena-Cagnani, C.E., Bergmann, K.-C., Bieber, T., Briggs, A.H., Brozek, J., Calderon, M.A., Dahl, R., Devillier, P., Gerth van Wijk, R., Howarth, P., Larenas, D., Papadopoulos, N.G., Schmid-Grendelmeier, P. and Zuberbier, T. (2011) How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy, 66 (6), 765-774. (doi:10.1111/j.1398-9995.2011.02590.x). (PMID:21496059)

Record type: Article

Abstract

Specific immunotherapy (SIT) is one of the treatments for allergic rhinitis. However, for allergists, nonspecialists, regulators, payers, and patients, there remain gaps in understanding the evaluation of randomized controlled trials (RCTs). Although treating the same diseases, RCTs in SIT and pharmacotherapy should be considered separately for several reasons, as developed in this study. These include the severity and persistence of allergic rhinitis in the patients enrolled in the study, the problem of the placebo, allergen exposure (in particular pollen and mite), the analysis and reporting of the study, the level of symptoms of placebo-treated patients, the clinical relevance of the efficacy of SIT, the need for a validated combined symptom-medication score, the differences between children and adults and pharmacoeconomic analyses. This statement reviews issues raised by the interpretation of RCTs in sublingual immunotherapy. It is not possible to directly extrapolate the rules or parameters used in medication RCTs to SIT. It also provides some suggestions for the research that will be needed. Interestingly, some of the research questions can be approached with the available data obtained from large RCTs

This record has no associated files available for download.

More information

e-pub ahead of print date: 18 April 2011
Published date: June 2011
Keywords: immunotherapy, randomized controlled trials, rhinitis, subcutaneous, sublingual, symptom score
Organisations: Clinical & Experimental Sciences

Identifiers

Local EPrints ID: 337427
URI: http://eprints.soton.ac.uk/id/eprint/337427
ISSN: 0105-4538
PURE UUID: c474558e-a88b-405d-86d3-7393f81c01ca

Catalogue record

Date deposited: 26 Apr 2012 08:38
Last modified: 14 Mar 2024 10:53

Export record

Altmetrics

Contributors

Author: J. Bousquet
Author: H.J. Schünemann
Author: P.J. Bousquet
Author: C. Bachert
Author: G.W. Canonica
Author: T.B. Casale
Author: P. Demoly
Author: S. Durham
Author: K.-H. Carlsen
Author: H.-J. Malling
Author: G. Passalacqua
Author: F.E.R. Simons
Author: J. Anto
Author: C.E. Baena-Cagnani
Author: K.-C. Bergmann
Author: T. Bieber
Author: A.H. Briggs
Author: J. Brozek
Author: M.A. Calderon
Author: R. Dahl
Author: P. Devillier
Author: R. Gerth van Wijk
Author: P. Howarth
Author: D. Larenas
Author: N.G. Papadopoulos
Author: P. Schmid-Grendelmeier
Author: T. Zuberbier

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×